Dr. Margaret Rhee, MD
Claim this profileVelocity Clinical Research
Studies Coronavirus
Studies Vital Signs Assessment
6 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Margaret Rhee, MD is currently running
PXVX0317 Booster
for Chikungunya
The purpose of this phase 3 multicenter, randomized, double-blind, placebo-controlled rollover study is to evaluate the safety and long-term immunogenicity of CHIKV VLP vaccine in adult and adolescent participants and to evaluate CHIKV VLP booster vaccine induced serum neutralizing antibody (SNA) response at 3, 4, or 5 years post-initial CHIKV VLP vaccination.
Recruiting1 award Phase 3
RSV Vaccine
for Respiratory Syncytial Virus
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 months of age) who may or may not have had prior respiratory syncytial virus (RSV) infection.
Recruiting0 awards Phase 1 & 2
More about Margaret Rhee, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Margaret Rhee, MD has experience with
- NVX CoV2373
- Web-based Application For Pulse Rate
- BLB-201
- PXVX0317
- VAX-31
- AQIVc
Breakdown of trials Margaret Rhee, MD has run
Coronavirus
Vital Signs Assessment
Respiratory Syncytial Virus
Chikungunya Fever
Chikungunya
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret Rhee, MD specialize in?
Margaret Rhee, MD focuses on Coronavirus and Vital Signs Assessment. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Margaret Rhee, MD currently recruiting for clinical trials?
Yes, Margaret Rhee, MD is currently recruiting for 2 clinical trials in Beachwood Ohio. If you're interested in participating, you should apply.
Are there any treatments that Margaret Rhee, MD has studied deeply?
Yes, Margaret Rhee, MD has studied treatments such as NVX CoV2373, Web-based Application for Pulse Rate, BLB-201.
What is the best way to schedule an appointment with Margaret Rhee, MD?
Apply for one of the trials that Margaret Rhee, MD is conducting.
What is the office address of Margaret Rhee, MD?
The office of Margaret Rhee, MD is located at: Velocity Clinical Research, Beachwood, Ohio 44122 United States. This is the address for their practice at the Velocity Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.